Clinical Trial Update: The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication [EARLY_Phase 1]

View source ↗

Summary

This update describes an early-phase 1 study evaluating the efficacy and safety of Keverprazan for eradicating Helicobacter pylori, with no recruitment yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Keverprazan

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Helicobacter Pylori Infection | EARLY_Phase 1 | Status: NOT_YET_RECRUITING